Biotech startups that raised Series A in MENA
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Remepy | Ramat Gan | Series A | $36.0M | 2026-08-12 |
| Scala Biodesign | Tel Aviv | Series A | $16.0M | 2026-03-31 |
| WeedOut | Ness Ziona | Series A | $8.1M | 2024-02-20 |
| Moodify | Kefar Sava | Series A | $10.6M | 2022-05-22 |
| Soos Technology | Kidron | Series A | $6.0M | 2021-03-01 |
| Myndlift | Tel Aviv | Series A | $3.9M | 2020-12-30 |
| BIO-NEXUS | Netanya | Series A | $3.0M | 2016-08-23 |
7 rows of the CSV in 5 of its 18 columns.
- The 46 biotech startups in MENA whose last round is Series A have raised $269.5M in total.
- 5 of them closed their most recent round in the last 12 months, $99.0M combined.
- The largest of those rounds is Remepy's $36.0M Series A, dated August 2026.
- Health care is the most common other sector, with 33 companies (72%).
- 13% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (48% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 46| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv, Israel | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
| WeedOut | WeedOut is a biotechnology company that provides weed control solutions. | Biotech | Ness Ziona, Israel | Series A | $8.1M | 2024-02-20 | Syngenta Ventures, Radicle Growth, Clay Capital +1 | 11 to 50 | 2016 | |
| BIO-NEXUS | BIO-NEXUS develops medical devices and systems. | Biotech | Netanya, Israel | Series A | $3.0M | 2016-08-23 | $3.0M | Springtide Ventures | 51 to 100 | 2010 |
| Quiet Therapeutics | Quiet Therapeutics is a biotech company developing a proprietary nanoparticle-based drug delivery system. | Biotech | Ness Ziona, Israel | Series A | $12.0M | 2015-04-12 | Jerusalem Global Ventures, Arkin Capital | 1 to 10 | 2009 |
Table 1. Biotech startups that raised Series A in MENA: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 46.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| 2 | Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv, Israel | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
Table 2. Biotech startups that raised Series A in MENA: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Firstime Venture Capital | Venture capital firm | Tel Aviv, Israel | 1 | 2% | 1 | Remepy |
| 2 | NFX | Startup accelerator | San Francisco, United States | 1 | 2% | 1 | Remepy |
| 3 | fresh.fund | Venture capital firm | Tel Aviv, Israel | 1 | 2% | 1 | Remepy |
| 4 | Vine Ventures | Venture capital firm | New York, United States | 1 | 2% | 1 | Remepy |
| 5 | Samsung NEXT | Corporate venture arm | Mountain View, United States | 1 | 2% | 1 | Remepy |
| 6 | Intel Ignite | Startup accelerator | Tel Aviv, Israel | 1 | 2% | 1 | Scala Biodesign |
| 7 | TLV Partners | Venture capital firm | Tel Aviv, Israel | 1 | 2% | 1 | Scala Biodesign |
| 8 | Intel Capital | Corporate venture arm | Santa Clara, United States | 1 | 2% | 1 | Scala Biodesign |
| 9 | Clay Capital | Venture capital firm | Singapore | 1 | 2% | ||
| 10 | Bunge Ventures | Corporate venture arm | Chesterfield, United States | 1 | 2% | ||
| 11 | Syngenta Ventures | Venture capital firm | Basel, Switzerland | 1 | 2% | ||
| 12 | Radicle Growth | Venture capital firm | San Diego, United States | 1 | 2% | ||
| 13 | ALIVE Israel HealthTech Fund | Venture capital firm | Tel Aviv, Israel | 1 | 2% | ||
| 14 | Trendlines Group | Venture capital firm | Misgav, Israel | 1 | 2% | ||
| 15 | OurCrowd | Venture capital firm | Jerusalem, Israel | 1 | 2% |
Table 3. Biotech startups that raised Series A in MENA: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 33 | 72% | $200.1M |
| Software | 11 | 24% | $86.1M |
| Artificial intelligence | 6 | 13% | $77.2M |
| Hardware | 3 | 7% | $27.0M |
| Commerce | 1 | 2% | |
| Fintech | 1 | 2% | |
| Cybersecurity | 1 | 2% |
Table 4. Biotech startups that raised Series A in MENA by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 46 | 100% | $9.0M |
Table 5. Biotech startups that raised Series A in MENA by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Israel | 42 | 91% |
| Egypt | 1 | 2% |
| United Arab Emirates | 1 | 2% |
| Turkey | 1 | 2% |
| Saudi Arabia | 1 | 2% |
Table 6. Biotech startups that raised Series A in MENA by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Jerusalem | 7 | 15% |
| Tel Aviv | 6 | 13% |
| Ness Ziona | 4 | 9% |
| Caesarea | 3 | 7% |
| Ramat Gan | 2 | 4% |
| Netanya | 2 | 4% |
| Yoqne`am `illit | 2 | 4% |
| Qiryat Shmona | 2 | 4% |
| Ramat Hasharon | 1 | 2% |
| Cairo | 1 | 2% |
| Acre | 1 | 2% |
| Misgav | 1 | 2% |
Table 7. Biotech startups that raised Series A in MENA by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 20% | $36.0M |
| May 2026 | 1 | 20% | $6.0M |
| March 2026 | 1 | 20% | $16.0M |
| February 2026 | 1 | 20% | $18.0M |
| December 2025 | 1 | 20% | $23.0M |
Table 8. Biotech startups that raised Series A in MENA: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 9% | $76.0M |
| 2025 | 2 | 4% | $26.9M |
| 2024 | 5 | 11% | $56.8M |
| 2023 | 2 | 4% | $13.0M |
| 2022 | 7 | 15% | $62.4M |
| 2021 | 5 | 11% | $30.0M |
Table 9. Biotech startups that raised Series A in MENA by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 6 | 13% |
| 2015 to 2019 | 23 | 50% |
| 2010 to 2014 | 9 | 20% |
| Before 2010 | 8 | 17% |
Table 10. Biotech startups that raised Series A in MENA by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 18 | 39% |
| 11 to 50 | 22 | 48% |
| 51 to 100 | 4 | 9% |
| 101 to 250 | 2 | 4% |
Table 11. Biotech startups that raised Series A in MENA by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in MENA. On 16 November 2026 that is 46 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 46 rows: 6 have no round amount, 0 no city and 20 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in MENA whose last round is Series A are on the list?
- 46, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 46 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.